Skip to Main Content
American Flag
LABOR DAY SALE

50% off your first year of any Quiver subscription

...

Use Promo Code:

LABOR26
American Flag

CRISPR Therapeutics AG

CRSP Real Time Price USD
N/A
N/A
N/A
...
Overview
Financials
Forecast
Insiders
Institutions
Compensation
Government
Ownership
News
Income
Balance Sheet
Cash Flow
Revenue Breakdown
CRSP Stock Insider Trading Activity Follow @QuiverQuant for major insider updates

---

Closing Price
Purchase
Sale
Name
Type
Shares
Price
Shares Held
Date
Reported
CRSP Stock Institutional Owners
Investor
Shares
Change in Shares
Market Value
Date
Reported
CRSP Derivatives Institutional Owners
Investor
Type
Shares
Change in Shares
Market Value
Date
Reported

Recently reported changes in CRSP holdings by institutional investors

Quarterly net insider trading by CRSP's directors and management

* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.

About

Backtest Start Date
CAGR (Total)
Return (30d)
Return (1Y)
  • 1M
  • 3M
  • 6M
  • YTD
  • 1Y
  • 2Y
  • 5Y
  • MAX

About

Backtest Start Date

Key Metrics

Return (1d)

Return (30d)

Return (1Y)

CAGR (Total)

Max Drawdown

Beta

Alpha

Sharpe Ratio

Win Rate

Average Win

Average Loss

Annual Volatility

Annual Std Dev

Information Ratio

Treynor Ratio

Total Trades

Show More
Metrics Definitions

Disclaimer: The performance results shown are based on historical backtesting and are hypothetical in nature. Backtested performance does not represent actual trading and does not account for all market factors that may affect execution, such as liquidity, slippage, and changing market conditions. Past performance is not necessarily indicative of future results. There is no guarantee that any trading strategy will be profitable or avoid losses.

  • Alpha

    Measures a portfolio's risk-adjusted performance against that of its benchmark

    Learn More about Alpha
  • Annual Standard Deviation

    Measures how much the portfolio's total return varies from its mean or average.

    Learn More about Annual Standard Deviation
  • Annual Volatility

    A statistical measure of the dispersion of returns for the portfolio.

    Learn More about Annual Volatility
  • Average Win

    The average return (%) for trades that resulted in a positive return.

  • Average Loss

    The average return (%) for trades that resulted in a negative return.

  • Beta

    A measure of the volatility of the portfolio compared to the market as a whole.

    Learn More about Beta
  • CAGR

    CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.

    Learn More about CAGR
  • Information Ratio

    A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.

    Learn More about Information Ratio
  • Max Drawdown

    the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.

    Learn More about Max Drawdown
  • Sharpe Ratio

    The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.

    Learn More about Sharpe Ratio
  • Total Trades

    The total number of trades made by this strategy.

  • Treynor Ratio

    Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.

    Learn More about Treynor Ratio
  • Win Rate

    The percentage of total trades that resulted in a positive return.

Subscribe to Quiver Premium for insider trading alerts

Be the first to see our newest insights and key updates across all datasets.

schema-2

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard

Former government officials who have lobbied for CRSP

8 former government officials from 5 congressional offices at 5 lobbying firms have lobbied for CRSP, most recently Apr 20, 2023.

  • Daniel Todd Senate Senior Health Counsel, Senate Finance Committee; Special Assistant, Office of Admin. Ctr. - Medicare & Medicaid Formerly Senior Health Counsel, Senate Finance Committee; Special Assistant, Office of Ad · TODD STRATEGY GROUP · Apr 20, 2023
  • John B. Shadegg
    Paul Edattel House Chief Health Counsel, House Energy & Commerce Committee; Policy Assistant, Office of the Speaker; Professional Staff Member for the Majority at the House Energy & Commerce Committee; Legislative Assistant & Legislative Director, Rep. John Shadegg Formerly with John B. Shadegg · TODD STRATEGY GROUP · Apr 20, 2023
  • Casey Caldwell Other Head of Government Affairs Formerly Head of Government Affairs · CRISPR THERAPEUTICS, INC. · Jan 18, 2022
  • John Martin Other Head of Government Affairs Formerly Head of Government Affairs · CRISPR THERAPEUTICS, INC. · Oct 19, 2021
  • Dianne Feinstein
    Lavita Legrys Senate New DHS-Dir/Office Leg. Affairs, Sr. Counselor/DHS Chief Procurement Officer, Sr. Adv./Asst. Sec. Private Sector; TSA-Assist. Admin. Leg. Affairs; SBA-Cong. & Public Liaison; Sen. Feinstein (D-CA)-Jud. Counsel; Jordan Immigration Commission-Legal Counsel Formerly with Dianne Feinstein · EMPIRE CONSULTING GROUP · Apr 20, 2021
  • John Ensign
    Aaron Cohen Senate New Chief of Staff & Legislative Assistant, Sen. John Ensign; Legislative Aide, Sen. Richard Bryan; Legislative Corresp., Sen. Richard Bryan. Formerly with John Ensign · CAPITOL COUNSEL LLC · Feb 16, 2021
  • Gregory W. Meeks
    Mike Mckay House New Sr. Advisor, Rep. Greg Meeks (D-NY) Formerly with Gregory W. Meeks · EMPIRE CONSULTING GROUP · Nov 27, 2019
  • Joseph Hogan Senate Deputy Chief of Staff, Sen. Ben Nelson Formerly Ben Nelson · ALPINE GROUP PARTNERS, LLC. · Oct 18, 2016

CRSP Estimated quarterly lobbying spending

Quiver Logo

No Corporate Lobbying data for this ticker

Corporate Lobbying Dashboard

CRSP Revenue by Segment or Geography

By Segment
By Geography
Quiver Logo

No Revenue by Segment data for this ticker

Revenue Breakdown Dashboard
Quiver Logo

No Revenue by Geography data for this ticker

Revenue Breakdown Dashboard
CRSP Income Statement
CRSP Balance Sheet
CRSP Cash Flow
U.S. Patents

New CRSP patent grants

  • Patent Title: Methods of manufacturing car-t cells Sep. 01, 2026
  • Patent Title: High fidelity rna-programmable endonuclease systems and uses thereof Sep. 01, 2026
  • Patent Title: Manufacturing process for making t cells expressing chimeric antigen receptors Aug. 04, 2026
  • Patent Title: Modulating expression of alas1 (5′-aminolevulinate synthase 1) gene Jun. 02, 2026
  • Patent Title: Universal donor cells Mar. 24, 2026
  • Patent Title: Universal donor cells Mar. 17, 2026
  • Patent Title: Universal donor cells Feb. 24, 2026
  • Patent Title: Genetically engineered t cells with ptpn2 knockout have improved functionality and anti-tumor activity Feb. 17, 2026
  • Patent Title: Universal donor cells Sep. 30, 2025
  • Patent Title: Universal donor cells Aug. 05, 2025
  • Patent Title: Universal donor cells Jul. 22, 2025
  • Patent Title: Genetically engineered t cells having improved persistence in culture Jul. 01, 2025
  • Patent Title: Gene-edited natural killer cells Jul. 01, 2025
  • Patent Title: T-cells expressing anti-liv1 chimeric antigen receptor May. 20, 2025
  • Patent Title: Optimized mrna encoding cas9 for use in lnps Apr. 01, 2025
  • Patent Title: Materials and methods for treatment of autosomal dominant retinitis pigmentosa Mar. 11, 2025
  • Patent Title: Compositions and methods for differentiating stem cells into nk cells Mar. 04, 2025
  • Patent Title: Methods and compositions for treating cancer Feb. 18, 2025
  • Patent Title: Compositions and methods for gene editing by targeting transferrin Feb. 04, 2025
  • Patent Title: Materials and methods for treatment of usher syndrome type 2a Feb. 04, 2025
  • Patent Title: Rna-programmable endonuclease systems and uses thereof Jan. 21, 2025
  • Patent Title: Messenger rna encoding cas9 for use in genome-editing systems Jan. 07, 2025
  • Patent Title: Materials and methods for treatment of hereditary haemochromatosis Jan. 07, 2025
  • Patent Title: Materials and methods for controlling gene editing Dec. 24, 2024
  • Patent Title: Materials and methods for treatment of usher syndrome type 2a and/or non-syndromic autosomal recessive retinitis pigmentosa (arrp) Oct. 22, 2024
  • Patent Title: Methods and compositions for treating angiopoietin-like 3 (angptl3) related conditions Jul. 16, 2024
  • Patent Title: Gene editing for hemophilia a with improved factor viii expression Jun. 25, 2024
  • Patent Title: Compositions and methods for the depletion of cd117+ cells Apr. 16, 2024
  • Patent Title: Masked chimeric antigen receptor specific to tyrosine-protein kinase like 7 (ptk7) and immune cells expressing such Mar. 12, 2024
  • Patent Title: Compositions and methods for gene editing Mar. 05, 2024
  • Patent Title: Materials and methods for treatment of glycogen storage disease type 1a Jan. 09, 2024
  • Patent Title: Genetically engineered t cells with regnase-1 and/or tgfbrii disruption have improved functionality and persistence Jan. 02, 2024
  • Patent Title: Materials and methods for treatment of alpha-1 antitrypsin deficiency Dec. 26, 2023
  • Patent Title: Methods and compositions for efficient gene deletion Dec. 05, 2023
  • Patent Title: Compositions and methods for genomic editing by insertion of donor polynucleotides Nov. 28, 2023
  • Patent Title: Anti-idiotype antibodies targeting anti-cd70 chimeric antigen receptor Oct. 24, 2023
  • Patent Title: Genetically engineered t cells with regnase-1 and/or tgfbrii disruption have improved functionality and persistence Jun. 20, 2023
  • Patent Title: Genetically engineered t cells with regnase-1 and/or tgfbrii disruption have improved functionality and persistence Jun. 20, 2023
  • Patent Title: Methods and compositions for treating cancer May. 16, 2023
  • Patent Title: Materials and methods for engineering cells and uses thereof in immuno-oncology Apr. 11, 2023
  • Patent Title: Gene-edited natural killer cells Feb. 28, 2023
  • Patent Title: Universal donor cells Feb. 14, 2023
  • Patent Title: Universal donor cells Jan. 31, 2023
  • Patent Title: Materials and methods for treatment of friedreich ataxia and other related disorders Jan. 31, 2023
  • Patent Title: Materials and methods for treatment of spinocerebellar ataxia type 1 (sca1) and other spinocerebellar ataxia type 1 protein (atxn1) gene related conditions or disorders Jan. 24, 2023
  • Patent Title: Gene editing for hemophilia a with improved factor viii expression Dec. 20, 2022
  • Patent Title: Genetically engineered t cells with regnase-1 and/or tgfbrii disruption have improved functionality and persistence Nov. 15, 2022
  • Patent Title: Compositions and methods for differentiating stem cells into nk cells Oct. 18, 2022
  • Patent Title: Materials and methods for engineering cells and uses thereof in immuno-oncology Oct. 18, 2022
  • Patent Title: Gene-edited natural killer cells Oct. 04, 2022
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard
Government Contracts

Estimated quarterly amount awarded to CRSP from public contracts

Quiver Logo

No recent Government Contracts for this ticker

Government Contracts Dashboard
CRSP News

Recent insights relating to CRSP

CNBC Recommendations

Recent picks made for CRSP stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in CRSP

CRSP Analyst Ratings

CRSP Stock Forecasts
...

  • ... Highest Price Target
  • ... Median Price Target
  • ... Lowest Price Target
CRSP Analyst Forecasts
Analyst
Firm
Current
Previous
Date
Frequently Asked Questions
  • Is $CRSP stock a Buy, Sell, or Hold?

  • What is the price target for $CRSP stock?

* Analyst consensus is not financial advice. Please see our data disclaimers .

CRSP Top Shareholders
Shareholder
Shares Held
CRSP Options Owners
Shareholder
Security
Underlying Shares
Frequently Asked Questions
  • Who owns $CRSP stock?

  • Who owns the most shares of $CRSP stock?

  • What funds own $CRSP stock?

* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.

CRSP Stock Smart Score

The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.

The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?

Sign Up to view CRSP Smart Score

Score Breakdown
Bull Case vs Bear Case

See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.

Example:

Bulls Say:

The Bulls Say summary highlights positive aspects of the stock.

Bears Say:

The Bears Say summary points out potential risks and negative aspects of the stock.

Show More
About CRSP

Crispr Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for clustered regularly interspaced short palindromic repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. The company is focused on using this technology to treat genetically defined diseases. Crispr's first approved drug is Casgevy, which was developed in collaboration with Vertex Pharmaceuticals and targets sickle-cell disease and transfusion-dependent beta-thalassemia. The company is advancing a variety of gene editing programs in immuno-oncology, cardiovascular, and a stem cell-derived therapy to treat Type 1 diabetes.

CRISPR Therapeutics AG (CRSP) Historical Stock Prices

CRISPR Therapeutics AG (CRSP) closed at $55.76 on September 23, 2026. Over the past year its adjusted close ranged from $44.34 to $76.78. Daily prices go back to October 19, 2016, 2,494 trading days in all.

  • 1 month-2.30%
  • 3 months+4.13%
  • Year to date+6.33%
  • 1 year-8.23%
  • 3 years+22.58%
  • 5 years-52.11%
  • Max+295.74%
See every congressional and insider trade on the CRSP price chart

Quiver Premium charts CRSP's full daily history since 2014 with each congressional purchase and sale and every open-market insider purchase marked on the price line, with hover details for each trade.

Upgrade to Premium

Last 12 months, newest first

Access Raw Data Daily prices since 2014 for every ticker, through the Quiver API
DateOpenHighLowCloseAdj. CloseVolume
Sep 23, 2026 59.10 59.52 54.67 55.76 55.76 2,362,536
Sep 22, 2026 58.73 60.72 57.64 59.03 59.03 2,083,545
Sep 21, 2026 57.98 59.24 56.87 58.33 58.33 1,814,156
Sep 18, 2026 58.00 59.34 55.63 56.56 56.56 3,382,855
Sep 17, 2026 53.90 59.21 53.12 57.33 57.33 3,000,240
Sep 16, 2026 52.16 53.67 51.83 52.21 52.21 2,667,362
Sep 15, 2026 52.57 52.84 51.49 51.83 51.83 1,248,406
Sep 14, 2026 51.33 53.80 51.33 52.96 52.96 1,525,143
Sep 11, 2026 52.35 53.21 51.62 51.72 51.72 856,710
Sep 10, 2026 52.50 52.62 51.72 52.26 52.26 1,262,233
Sep 9, 2026 54.59 54.90 53.31 53.45 53.45 1,184,581
Sep 8, 2026 54.45 55.10 52.78 54.78 54.78 1,386,186
Sep 4, 2026 56.06 57.21 55.35 55.79 55.79 904,292
Sep 3, 2026 57.50 57.80 55.72 56.49 56.49 1,491,345
Sep 2, 2026 57.13 58.96 55.59 56.92 56.92 911,120
Sep 1, 2026 56.22 57.13 55.43 56.82 56.82 890,824
Aug 31, 2026 56.55 57.49 56.20 56.98 56.98 1,391,037
Aug 28, 2026 58.22 59.37 57.10 57.72 57.72 1,388,793
Aug 27, 2026 59.12 60.11 58.02 59.37 59.37 1,188,519
Aug 26, 2026 60.18 60.39 58.06 59.23 59.23 959,931
Aug 25, 2026 57.93 61.55 57.51 60.90 60.90 2,083,671
Aug 24, 2026 58.75 58.96 56.62 57.08 57.08 1,119,658
Aug 21, 2026 59.72 62.53 58.89 59.50 59.50 2,453,841
Aug 20, 2026 58.73 60.90 56.94 58.12 58.12 2,910,358
Aug 19, 2026 55.00 59.91 54.98 59.81 59.81 3,843,325
Aug 18, 2026 53.20 53.88 51.80 52.97 52.97 1,313,927
Aug 17, 2026 53.08 54.57 52.61 54.28 54.28 958,154
Aug 14, 2026 53.99 54.00 52.23 53.55 53.55 807,993
Aug 13, 2026 54.28 54.70 53.50 53.99 53.99 909,128
Aug 12, 2026 54.30 55.02 53.46 53.99 53.99 742,904
Aug 11, 2026 53.88 54.69 53.12 54.07 54.07 1,066,370
Aug 10, 2026 53.50 54.68 53.10 53.51 53.51 1,186,852
Aug 7, 2026 52.58 54.17 52.18 53.52 53.52 1,284,024
Aug 6, 2026 52.55 53.11 51.51 51.64 51.64 1,025,534
Aug 5, 2026 53.00 53.33 51.81 52.45 52.45 1,619,793
Aug 4, 2026 50.55 53.20 50.16 53.07 53.07 2,142,953
Aug 3, 2026 48.04 49.90 47.50 49.57 49.57 1,405,142
Jul 31, 2026 48.54 49.03 47.31 47.99 47.99 1,036,287
Jul 30, 2026 47.70 48.73 47.50 48.44 48.44 1,380,559
Jul 29, 2026 47.42 48.15 46.82 47.64 47.64 1,894,791
Jul 28, 2026 46.60 48.00 45.89 47.55 47.55 2,080,892
Jul 27, 2026 47.66 48.28 46.71 46.73 46.73 1,335,137
Jul 24, 2026 47.92 48.07 45.90 46.54 46.54 1,389,563
Jul 23, 2026 47.00 48.35 46.46 47.53 47.53 1,713,250
Jul 22, 2026 48.00 48.10 46.72 47.24 47.24 2,409,276
Jul 21, 2026 46.99 48.62 46.86 48.15 48.15 1,384,175
Jul 20, 2026 47.78 48.36 46.99 46.99 46.99 1,647,457
Jul 17, 2026 47.47 48.62 47.09 47.78 47.78 1,620,299
Jul 16, 2026 50.65 50.77 47.87 48.57 48.57 2,101,227
Jul 15, 2026 50.51 51.49 49.88 51.37 51.37 1,318,799
Jul 14, 2026 50.56 51.00 49.33 50.46 50.46 1,726,808
Jul 13, 2026 52.39 52.96 50.18 50.63 50.63 1,965,019
Jul 10, 2026 56.30 56.65 52.05 53.35 53.35 2,074,867
Jul 9, 2026 59.24 60.50 55.88 56.34 56.34 1,436,133
Jul 8, 2026 58.51 60.33 57.57 59.20 59.20 1,226,594
Jul 7, 2026 62.45 62.80 58.58 60.77 60.77 1,668,275
Jul 6, 2026 59.38 63.45 58.50 61.89 61.89 2,050,998
Jul 2, 2026 56.18 61.68 56.18 60.08 60.08 2,931,688
Jul 1, 2026 54.57 57.25 54.56 55.62 55.62 965,525
Jun 30, 2026 56.35 56.47 54.45 54.54 54.54 1,188,353
Jun 29, 2026 55.12 57.91 53.74 56.35 56.35 1,844,481
Jun 26, 2026 53.70 56.15 53.31 54.92 54.92 3,392,915
Jun 25, 2026 54.20 56.70 53.55 53.98 53.98 2,092,304
Jun 24, 2026 54.15 55.48 53.35 53.55 53.55 1,411,458
Jun 23, 2026 53.53 56.06 53.13 53.99 53.99 1,534,124
Jun 22, 2026 54.85 56.08 54.08 54.36 54.36 1,135,637
Jun 18, 2026 54.41 55.79 53.02 54.09 54.09 1,941,408
Jun 17, 2026 52.59 55.10 51.64 53.09 53.09 2,097,504
Jun 16, 2026 52.68 53.27 51.28 52.02 52.02 1,103,358
Jun 15, 2026 51.00 53.27 50.76 52.61 52.61 1,828,501
Jun 12, 2026 49.79 51.24 49.71 49.80 49.80 1,150,878
Jun 11, 2026 50.09 51.13 49.02 50.23 50.23 1,514,982
Jun 10, 2026 51.44 52.45 49.41 49.44 49.44 1,409,159
Jun 9, 2026 52.55 53.09 49.58 51.48 51.48 1,461,841
Jun 8, 2026 52.71 52.90 51.09 51.60 51.60 1,131,621
Jun 5, 2026 55.99 55.99 51.15 51.84 51.84 2,298,183
Jun 4, 2026 52.42 59.00 52.29 56.95 56.95 3,300,962
Jun 3, 2026 51.46 52.28 50.52 52.08 52.08 1,271,731
Jun 2, 2026 53.26 53.59 51.85 52.02 52.02 1,372,827
Jun 1, 2026 55.11 55.26 53.68 54.19 54.19 1,426,137
May 29, 2026 56.38 56.39 54.27 56.18 56.18 1,932,828
May 28, 2026 53.04 57.24 52.38 56.38 56.38 2,665,550
May 27, 2026 51.71 54.52 51.11 53.53 53.53 1,840,890
May 26, 2026 50.68 51.87 50.19 51.59 51.59 1,454,909
May 22, 2026 49.92 51.11 49.92 50.36 50.36 1,550,761
May 21, 2026 47.71 50.05 47.34 49.90 49.90 1,447,182
May 20, 2026 47.73 49.06 47.20 48.55 48.55 1,724,979
May 19, 2026 48.12 48.33 46.92 47.59 47.59 1,689,050
May 18, 2026 48.78 50.08 48.07 48.56 48.56 1,779,093
May 15, 2026 49.74 50.45 48.25 48.41 48.41 1,978,747
May 14, 2026 52.90 53.49 50.23 50.45 50.45 1,664,361
May 13, 2026 52.83 53.81 52.36 52.75 52.75 924,858
May 12, 2026 54.17 54.17 52.02 52.83 52.83 973,699
May 11, 2026 55.23 56.16 53.84 54.01 54.01 1,317,773
May 8, 2026 53.05 55.85 52.55 54.83 54.83 1,733,486
May 7, 2026 54.52 55.47 51.70 52.42 52.42 1,518,875
May 6, 2026 53.00 55.40 52.65 55.08 55.08 2,529,831
May 5, 2026 52.60 53.94 49.38 52.38 52.38 3,102,096
May 4, 2026 51.77 54.41 51.77 53.58 53.58 1,711,808
May 1, 2026 51.59 52.56 50.59 51.63 51.63 1,035,742
Apr 30, 2026 51.32 52.73 50.70 52.34 52.34 1,300,056
Apr 29, 2026 51.06 52.15 50.48 50.71 50.71 1,539,773
Apr 28, 2026 50.51 52.28 50.12 52.06 52.06 1,570,540
Apr 27, 2026 50.59 54.04 50.26 50.99 50.99 2,933,183
Apr 24, 2026 55.01 55.18 48.77 48.78 48.78 3,851,265
Apr 23, 2026 56.88 57.99 55.09 55.18 55.18 1,521,115
Apr 22, 2026 56.58 57.00 55.11 56.42 56.42 1,427,325
Apr 21, 2026 57.46 58.47 55.39 55.54 55.54 2,249,704
Apr 20, 2026 57.14 58.60 56.87 57.69 57.69 1,263,812
Apr 17, 2026 57.35 59.16 57.05 57.99 57.99 1,801,497
Apr 16, 2026 56.84 57.24 54.57 55.72 55.72 1,713,551
Apr 15, 2026 57.15 59.39 55.76 56.76 56.76 1,982,306
Apr 14, 2026 55.55 57.77 55.35 56.86 56.86 2,103,920
Apr 13, 2026 51.09 55.09 51.05 54.83 54.83 1,843,791
Apr 10, 2026 51.75 52.22 49.50 51.22 51.22 871,733
Apr 9, 2026 51.27 52.27 51.10 51.72 51.72 1,100,109
Apr 8, 2026 52.00 52.61 50.19 51.76 51.76 1,723,539
Apr 7, 2026 49.12 49.76 47.87 49.70 49.70 1,319,473
Apr 6, 2026 49.70 50.77 49.05 49.15 49.15 1,145,482
Apr 2, 2026 47.10 49.95 47.10 49.51 49.51 1,727,877
Apr 1, 2026 47.89 49.95 47.89 48.81 48.81 1,310,055
Mar 31, 2026 44.99 47.60 44.91 47.57 47.57 2,167,721
Mar 30, 2026 45.89 45.96 44.12 44.34 44.34 1,617,614
Mar 27, 2026 47.23 47.83 45.35 45.75 45.75 1,594,437
Mar 26, 2026 46.43 48.80 46.40 47.55 47.55 1,263,112
Mar 25, 2026 47.25 48.30 47.05 47.09 47.09 1,081,181
Mar 24, 2026 46.18 46.96 45.12 46.43 46.43 1,185,746
Mar 23, 2026 46.66 47.92 46.40 46.88 46.88 1,443,348
Mar 20, 2026 46.49 47.66 45.88 46.24 46.24 2,561,311
Mar 19, 2026 46.90 48.20 46.32 46.95 46.95 2,235,904
Mar 18, 2026 49.29 49.50 47.55 47.69 47.69 1,476,142
Mar 17, 2026 48.90 50.19 48.54 50.09 50.09 1,874,072
Mar 16, 2026 49.50 50.09 47.72 48.42 48.42 2,258,134
Mar 13, 2026 49.70 50.07 47.53 48.75 48.75 1,972,820
Mar 12, 2026 49.35 49.50 48.20 48.87 48.87 3,289,995
Mar 11, 2026 52.12 52.12 49.84 49.93 49.93 6,326,420
Mar 10, 2026 53.94 55.40 50.66 52.80 52.80 9,434,588
Mar 9, 2026 55.59 59.06 55.00 58.78 58.78 1,261,684
Mar 6, 2026 55.11 57.04 54.80 56.50 56.50 1,167,922
Mar 5, 2026 58.63 59.82 56.55 57.33 57.33 1,542,507
Mar 4, 2026 58.82 60.60 57.75 60.00 60.00 1,173,963
Mar 3, 2026 58.01 59.37 56.41 58.06 58.06 1,470,493
Mar 2, 2026 58.04 61.00 57.25 60.77 60.77 1,332,751
Feb 27, 2026 59.50 61.49 58.50 60.14 60.14 1,690,620
Feb 26, 2026 54.87 61.76 53.75 61.74 61.74 3,663,336
Feb 25, 2026 57.57 58.50 55.14 55.20 55.20 1,223,077
Feb 24, 2026 54.04 57.30 54.01 56.77 56.77 1,690,103
Feb 23, 2026 52.21 54.83 52.02 53.98 53.98 1,280,714
Feb 20, 2026 54.03 55.05 52.92 53.46 53.46 1,297,665
Feb 19, 2026 52.01 54.70 52.00 54.64 54.64 984,185
Feb 18, 2026 52.88 54.03 52.59 53.52 53.52 1,233,156
Feb 17, 2026 53.00 54.44 51.92 53.17 53.17 1,688,059
Feb 13, 2026 49.74 54.10 49.62 53.07 53.07 2,465,665
Feb 12, 2026 48.66 49.00 47.39 48.93 48.93 1,532,605
Feb 11, 2026 49.30 49.30 46.48 48.32 48.32 1,337,321
Feb 10, 2026 49.36 50.63 48.69 48.83 48.83 1,312,936
Feb 9, 2026 48.52 49.83 47.37 49.70 49.70 1,409,264
Feb 6, 2026 47.22 48.99 46.27 48.74 48.74 1,669,534
Feb 5, 2026 48.85 49.63 45.53 45.88 45.88 2,627,305
Feb 4, 2026 51.89 52.37 48.82 50.17 50.17 1,856,918
Feb 3, 2026 51.23 53.00 50.61 52.00 52.00 1,386,440
Feb 2, 2026 49.50 51.92 49.10 51.31 51.31 1,714,783
Jan 30, 2026 52.12 53.84 49.73 49.96 49.96 2,243,455
Jan 29, 2026 53.03 54.09 52.67 53.35 53.35 1,567,943
Jan 28, 2026 54.30 54.63 53.07 53.69 53.69 1,218,538
Jan 27, 2026 55.50 56.69 53.57 54.26 54.26 1,357,181
Jan 26, 2026 54.77 55.71 53.72 54.65 54.65 1,352,002
Jan 23, 2026 60.70 60.70 55.05 55.52 55.52 2,393,076
Jan 22, 2026 54.53 60.86 54.22 60.81 60.81 3,428,010
Jan 21, 2026 52.14 54.80 51.80 54.73 54.73 1,570,918
Jan 20, 2026 52.02 53.46 51.00 52.61 52.61 1,808,760
Jan 16, 2026 54.15 54.75 53.10 53.51 53.51 1,409,225
Jan 15, 2026 56.92 57.31 54.04 54.21 54.21 1,507,105
Jan 14, 2026 55.98 57.99 55.30 56.89 56.89 1,770,546
Jan 13, 2026 55.69 56.64 54.12 56.18 56.18 1,540,970
Jan 12, 2026 54.00 55.70 53.37 55.30 55.30 1,951,241
Jan 9, 2026 56.96 57.37 53.68 53.84 53.84 2,100,794
Jan 8, 2026 57.74 57.74 56.03 56.40 56.40 1,511,734
Jan 7, 2026 58.72 59.89 57.30 57.99 57.99 1,900,352
Jan 6, 2026 55.13 60.73 54.90 58.19 58.19 2,863,487
Jan 5, 2026 53.82 55.52 53.73 55.15 55.15 1,936,990
Jan 2, 2026 52.72 54.27 52.10 53.77 53.77 1,373,189
Dec 31, 2025 53.13 53.46 52.35 52.44 52.44 1,383,494
Dec 30, 2025 54.06 54.12 52.98 53.19 53.19 1,363,787
Dec 29, 2025 54.59 55.41 53.80 53.97 53.97 1,279,779
Dec 26, 2025 56.48 56.54 53.76 55.08 55.08 1,410,636
Dec 24, 2025 56.45 56.83 55.21 56.71 56.71 652,969
Dec 23, 2025 57.10 57.24 55.81 56.46 56.46 1,343,291
Dec 22, 2025 56.02 59.18 54.50 57.91 57.91 2,103,057
Dec 19, 2025 55.35 56.68 55.00 55.86 55.86 3,283,623
Dec 18, 2025 54.90 57.03 54.77 54.84 54.84 1,335,412
Dec 17, 2025 55.74 58.00 54.60 54.74 54.74 1,175,613
Dec 16, 2025 55.68 57.58 55.29 55.97 55.97 1,144,669
Dec 15, 2025 57.12 58.35 55.65 56.25 56.25 1,565,200
Dec 12, 2025 57.95 58.50 55.52 56.68 56.68 1,402,459
Dec 11, 2025 56.85 59.24 56.61 58.09 58.09 1,348,891
Dec 10, 2025 56.34 58.47 54.41 57.59 57.59 1,570,928
Dec 9, 2025 57.00 58.00 55.65 57.04 57.04 2,169,160
Dec 8, 2025 58.12 58.76 56.68 57.36 57.36 1,309,474
Dec 5, 2025 58.17 58.76 56.01 56.88 56.88 1,660,255
Dec 4, 2025 55.99 59.77 54.93 58.18 58.18 3,111,106
Dec 3, 2025 51.49 56.01 51.16 55.99 55.99 1,948,883
Dec 2, 2025 52.43 53.03 51.20 51.58 51.58 1,416,528
Dec 1, 2025 52.30 53.46 51.00 52.17 52.17 2,287,576
Nov 28, 2025 52.84 54.00 51.50 53.47 53.47 1,406,810
Nov 26, 2025 53.63 53.78 52.30 53.30 53.30 2,084,305
Nov 25, 2025 50.89 53.89 49.96 53.57 53.57 2,359,109
Nov 24, 2025 50.40 51.51 49.31 51.25 51.25 2,488,792
Nov 21, 2025 48.48 51.45 48.02 50.23 50.23 2,753,748
Nov 20, 2025 51.61 53.20 48.24 49.29 49.29 2,370,436
Nov 19, 2025 53.83 53.83 50.56 50.73 50.73 1,736,906
Nov 18, 2025 54.55 54.99 52.07 53.47 53.47 2,436,838
Nov 17, 2025 51.36 55.77 51.22 55.32 55.32 4,451,365
Nov 14, 2025 49.58 54.77 49.11 52.53 52.53 4,266,817
Nov 13, 2025 51.70 51.78 50.27 51.11 51.11 2,919,602
Nov 12, 2025 55.31 55.69 52.05 52.19 52.19 2,760,506
Nov 11, 2025 54.18 56.15 52.82 55.21 55.21 2,116,003
Nov 10, 2025 58.06 58.48 53.83 54.58 54.58 2,349,631
Nov 7, 2025 53.61 55.22 52.42 55.12 55.12 2,936,609
Nov 6, 2025 56.51 58.75 54.57 56.61 56.61 2,745,943
Nov 5, 2025 56.50 57.23 54.91 56.99 56.99 2,083,556
Nov 4, 2025 59.97 60.64 56.00 56.41 56.41 3,280,643
Nov 3, 2025 63.02 64.74 60.53 61.97 61.97 1,922,535
Oct 31, 2025 61.19 65.98 60.53 63.99 63.99 3,020,777
Oct 30, 2025 61.81 62.77 60.91 61.10 61.10 1,545,039
Oct 29, 2025 64.30 65.05 61.71 62.56 62.56 1,771,940
Oct 28, 2025 65.66 65.71 63.59 64.17 64.17 1,855,622
Oct 27, 2025 67.12 67.73 64.10 65.72 65.72 3,004,765
Oct 24, 2025 68.20 68.71 66.85 67.61 67.61 1,342,612
Oct 23, 2025 66.61 67.49 65.45 67.21 67.21 1,553,012
Oct 22, 2025 70.10 70.73 64.80 66.52 66.52 3,193,011
Oct 21, 2025 73.79 75.06 71.00 72.32 72.32 1,865,205
Oct 20, 2025 71.13 74.43 70.80 73.97 73.97 2,688,416
Oct 17, 2025 67.55 69.56 67.00 69.15 69.15 2,006,969
Oct 16, 2025 70.00 71.52 67.82 68.43 68.43 2,580,655
Oct 15, 2025 70.01 73.09 69.80 71.82 71.82 2,366,334
Oct 14, 2025 67.50 71.31 64.80 69.38 69.38 2,521,720
Oct 13, 2025 75.12 75.16 67.90 68.29 68.29 3,193,443
Oct 10, 2025 77.33 78.00 70.30 73.07 73.07 3,840,649
Oct 9, 2025 77.80 78.38 73.55 74.92 74.92 2,676,759
Oct 8, 2025 71.19 78.48 70.77 76.78 76.78 5,868,198
Oct 7, 2025 70.31 71.15 68.26 70.62 70.62 1,543,848
Oct 6, 2025 68.01 71.64 67.38 70.19 70.19 2,477,827
Oct 3, 2025 73.88 73.95 67.71 67.74 67.74 3,679,342
Oct 2, 2025 67.26 72.95 66.57 72.82 72.82 4,280,524
Oct 1, 2025 64.75 66.70 64.66 66.16 66.16 1,956,630
Sep 30, 2025 63.81 66.29 62.62 64.81 64.81 2,576,343
Sep 29, 2025 62.15 64.20 61.56 63.77 63.77 2,116,938
Sep 26, 2025 60.35 61.69 58.49 61.67 61.67 1,957,222
Sep 25, 2025 58.98 61.16 58.40 60.32 60.32 1,781,110
Sep 24, 2025 61.13 63.50 60.30 61.05 61.05 2,165,981
Sep 23, 2025 61.63 63.63 60.31 60.76 60.76 2,355,824

Open, high, low and close are the prices as traded. Adjusted close accounts for splits and dividends, and is what the chart and returns use. Where a company changed its ticker, its history under the old symbol is included.

Need daily prices for every ticker, in code?

The Quiver API serves daily prices back to 2014 alongside congressional trades, insider trades, 13F holdings and lobbying, all under one key and inside Claude or ChatGPT through our MCP server.

Explore the Quiver API
CRISPR Therapeutics AG Executive Compensation

We estimate that -- received a compensation of -- in --, making them the highest paid executive at CRSP, per a recent SEC DEF 14A filing.



Name
Role
Salary
Bonus
Stock/Option Awards
Total Compensation